JP2009502803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502803A5 JP2009502803A5 JP2008522960A JP2008522960A JP2009502803A5 JP 2009502803 A5 JP2009502803 A5 JP 2009502803A5 JP 2008522960 A JP2008522960 A JP 2008522960A JP 2008522960 A JP2008522960 A JP 2008522960A JP 2009502803 A5 JP2009502803 A5 JP 2009502803A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- polyethylene glycol
- polypeptide
- seq
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70090505P | 2005-07-20 | 2005-07-20 | |
| PCT/US2006/028215 WO2007012033A2 (en) | 2005-07-20 | 2006-07-20 | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009502803A JP2009502803A (ja) | 2009-01-29 |
| JP2009502803A5 true JP2009502803A5 (enExample) | 2009-09-03 |
Family
ID=37600989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522960A Pending JP2009502803A (ja) | 2005-07-20 | 2006-07-20 | Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20070053933A1 (enExample) |
| EP (1) | EP1912668A2 (enExample) |
| JP (1) | JP2009502803A (enExample) |
| AU (1) | AU2006269908A1 (enExample) |
| CA (1) | CA2616122A1 (enExample) |
| IL (1) | IL188350A0 (enExample) |
| WO (1) | WO2007012033A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| JP4808157B2 (ja) * | 2003-08-07 | 2011-11-02 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９の均一な調製物 |
| AU2005231476B2 (en) | 2004-04-02 | 2011-09-01 | Zymogenetics, Inc. | Il-28 and il-29 cysteine mutants for treating viral infection |
| EP1909821A2 (en) * | 2005-07-20 | 2008-04-16 | ZymoGenetics, Inc. | Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| JP2009502803A (ja) * | 2005-07-20 | 2009-01-29 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法 |
| WO2007042884A1 (en) * | 2005-10-07 | 2007-04-19 | Pfizer Products Inc. | Vaccines and methods to treat canine influenza |
| RU2496514C2 (ru) * | 2008-06-05 | 2013-10-27 | Займоджинетикс, Инк. | Применение пэгилированных интерферонов типа iii для лечения гепатита с |
| US20100093618A1 (en) * | 2008-10-15 | 2010-04-15 | Quinto Ileana | Polypeptide capable of inhibiting hiv-1 transcription and replication and uses thereof |
| EP2350124A1 (en) * | 2008-11-20 | 2011-08-03 | Zymogenetics, Inc. | Il-29 mutants and uses thereof |
| US20100316604A1 (en) * | 2009-04-21 | 2010-12-16 | Asterion Limited | Interferon lambda fusion polypeptides |
| US10076512B2 (en) | 2014-05-01 | 2018-09-18 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| US11311519B2 (en) | 2014-05-01 | 2022-04-26 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| CN103923209B (zh) * | 2014-05-13 | 2016-06-22 | 北京凯因科技股份有限公司 | 一种Lambda干扰素突变体及聚乙二醇衍生物 |
| CN105085658B (zh) * | 2014-05-14 | 2019-12-24 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体及聚乙二醇衍生物 |
| HUE054068T2 (hu) | 2015-04-21 | 2021-08-30 | Eiger Biopharmaceuticals Inc | Lonafarnibot és Ritonavirt tartalmazó gyógyszerkészítmények |
| RS61944B1 (sr) | 2016-02-19 | 2021-07-30 | Eiger Biopharmaceuticals Inc | Lečenje infekcije hepatitis delta virusom sa interferonom lambda |
| CN112694526B (zh) * | 2020-05-27 | 2023-01-20 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白 |
| CN115667291B (zh) | 2020-05-27 | 2025-08-05 | 杭州先为达生物科技股份有限公司 | 一种白细胞介素29突变体蛋白 |
| WO2024241086A1 (en) * | 2023-05-24 | 2024-11-28 | Ambrx, Inc. | Pegylated bovine interferon lambda and methods of use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4853332A (en) * | 1982-10-19 | 1989-08-01 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins |
| US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US6468776B1 (en) * | 2000-03-03 | 2002-10-22 | Zymogenetics, Inc. | Human serine protease |
| ES2286128T3 (es) * | 2000-06-30 | 2007-12-01 | Zymogenetics, Inc. | Proteina zcyto21 tipo interferon. |
| US6822082B2 (en) * | 2000-06-30 | 2004-11-23 | Zymogenetics, Inc. | Polynucleotides for mammalian secreted protein, Z1055G2P |
| US7038032B2 (en) * | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CN1659274A (zh) * | 2002-04-19 | 2005-08-24 | 津莫吉尼蒂克斯公司 | 细胞因子受体 |
| CA2503305A1 (en) * | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| JP4808157B2 (ja) * | 2003-08-07 | 2011-11-02 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９の均一な調製物 |
| AU2005231476B2 (en) * | 2004-04-02 | 2011-09-01 | Zymogenetics, Inc. | Il-28 and il-29 cysteine mutants for treating viral infection |
| US7351689B2 (en) * | 2004-07-29 | 2008-04-01 | Zymogenetics, Inc. | Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
| JP2009502803A (ja) * | 2005-07-20 | 2009-01-29 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法 |
| EP1909821A2 (en) * | 2005-07-20 | 2008-04-16 | ZymoGenetics, Inc. | Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| JP5364375B2 (ja) * | 2005-10-04 | 2013-12-11 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２９の生産および精製の方法 |
-
2006
- 2006-07-20 JP JP2008522960A patent/JP2009502803A/ja active Pending
- 2006-07-20 WO PCT/US2006/028215 patent/WO2007012033A2/en not_active Ceased
- 2006-07-20 CA CA002616122A patent/CA2616122A1/en not_active Abandoned
- 2006-07-20 US US11/458,945 patent/US20070053933A1/en not_active Abandoned
- 2006-07-20 EP EP06787996A patent/EP1912668A2/en not_active Withdrawn
- 2006-07-20 AU AU2006269908A patent/AU2006269908A1/en not_active Abandoned
-
2007
- 2007-12-24 IL IL188350A patent/IL188350A0/en unknown
-
2011
- 2011-03-07 US US13/042,083 patent/US20110182852A1/en not_active Abandoned
- 2011-12-20 US US13/331,000 patent/US20120114590A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502800A5 (enExample) | ||
| JP2010534684A5 (enExample) | ||
| JP2005516885A5 (enExample) | ||
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| JP2014530253A5 (enExample) | ||
| JP2010505444A5 (enExample) | ||
| JP2003503454A5 (enExample) | ||
| JP2013515055A5 (enExample) | ||
| JP2012532601A5 (enExample) | ||
| JP2013507132A5 (enExample) | ||
| NZ603623A (en) | Tcr complex immunotherapeutics | |
| JP2012176978A5 (enExample) | ||
| EP2174668A3 (en) | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis | |
| JP2013519697A5 (enExample) | ||
| WO2009043353A3 (en) | Micromirs | |
| JP2011528896A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| JP2009504138A5 (enExample) | ||
| JP2007510403A5 (enExample) | ||
| JP2005529870A5 (enExample) | ||
| EP2028220A4 (en) | MOLDED ARTICLE AND METHOD FOR PRODUCING THE SAID ARTICLE | |
| JP2014513941A5 (enExample) | ||
| JP2009256608A5 (enExample) | ||
| JP2008517059A5 (enExample) | ||
| JP2007533298A5 (enExample) |